Management of Atopic Dermatitis: Therapeutic Advances

Saakshi Khattri, MD


June 21, 2022

Saakshi Khattri, MD, describes a state of unceasing misery for a young patient who, while coping with the exacting symptoms of a nearly lifelong case of atopic dermatitis (AD), was treated with the monoclonal antibody dupilumab.

Dr Khattri recalls the impression that this patient left as they were relieved from the acute suffering inflicted by this often disabling disorder.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.